Intestinal flora testing uses next-generation high-throughput sequencing platform, based on the 16S rDNA sequencing technology in the Human Microbiome Project, to detect the type and quantity of human intestinal flora, and analyze the intestinal microecological environment of the subjects ( the overall situation of the flora, the content of probiotics and pathogenic bacteria, etc.), to assess the risk of diabetes, obesity and irritable bowel syndrome and other diseases and immune status, and to provide the subjects with personalized health conditioning programs, thereby promoting the balance of intestinal flora and improving the health of the subjects.